What is the recommended follow-up schedule for a 12-year-old patient with Noonan Syndrome, a pulmonary valve (PV) gradient of 12 mmHg, and no cardiovascular signs or symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Follow-up Schedule for a 12-Year-Old with Noonan Syndrome and Mild Pulmonary Valve Stenosis

For a 12-year-old with Noonan Syndrome who has a pulmonary valve gradient of 12 mmHg (mean 6.8 mmHg), no branch pulmonary stenosis, no LVH, normal echo, and no cardiovascular symptoms, follow-up with physical examination, echocardiography-Doppler, and ECG should be performed at 5-year intervals. 1

Classification and Management of Pulmonary Stenosis

Severity Classification

  • Pulmonary stenosis (PS) is classified as mild when the peak gradient across the valve is less than 30 mmHg, moderate when 30-50 mmHg, and severe when greater than 50 mmHg 1
  • The patient's peak gradient of 12 mmHg clearly falls into the mild category

Natural History of Mild PS

  • Stenosis is rarely progressive when the initial gradient is mild 1
  • Patients with mild PS generally have excellent outcomes with conservative management 1

Follow-up Recommendations Based on Guidelines

Recommended Follow-up Schedule

  • Class I recommendation (Level of Evidence: C): A follow-up physical examination, echocardiography-Doppler, and ECG are recommended at 5-year intervals in asymptomatic patients with peak instantaneous valvular gradient by Doppler less than 30 mmHg 1
  • This 5-year interval is appropriate for this patient given:
    • Mild PS (gradient 12 mmHg)
    • Absence of symptoms
    • Normal cardiac function
    • No other cardiac abnormalities

Special Considerations for Noonan Syndrome

  • Noonan syndrome patients have a higher prevalence of cardiovascular abnormalities (62.1%), including PS (51.1%), hypertrophic cardiomyopathy (33.3%), and atrial septal defects (27.3%) 2, 3
  • Dysplastic pulmonary valves are seen in approximately 35.3% of Noonan syndrome patients with PS 2
  • Patients with Noonan syndrome should be monitored for development of other cardiac issues, even with mild PS 4, 5

What to Monitor During Follow-up Visits

Physical Examination

  • Listen for changes in murmur intensity or character 1
  • Assess for signs of right ventricular enlargement or dysfunction 1
  • Monitor for development of new symptoms such as exercise intolerance 1

Echocardiography-Doppler

  • Track PS gradient for any progression 1
  • Assess right ventricular size and function 1
  • Monitor pulmonary valve mobility and morphology 1
  • Evaluate for development of pulmonary regurgitation 1

Electrocardiogram

  • Monitor for development of right ventricular hypertrophy 1
  • Assess for arrhythmias, which can develop in Noonan syndrome patients 5
  • Look for specific Noonan syndrome-related ECG features such as left axis deviation, small left precordial R-waves, and large right precordial S-waves 5

When to Consider More Frequent Follow-up

  • If the PS gradient increases to >30 mmHg, follow-up should be increased to every 2-5 years 1
  • Development of symptoms should prompt immediate reevaluation 1
  • Signs of right ventricular enlargement or dysfunction should trigger more frequent monitoring 1
  • Development of arrhythmias would necessitate closer follow-up 1

Pitfalls to Avoid

  • Don't underestimate the importance of regular follow-up even with mild PS, as Noonan syndrome patients can develop other cardiac issues over time 4, 3
  • Be vigilant for the development of hypertrophic cardiomyopathy, which is associated with sudden death in Noonan syndrome 2
  • Don't rely solely on symptoms, as significant progression can occur before symptoms develop 1
  • Remember that Noonan syndrome patients may have ECG abnormalities even in the absence of structural heart disease 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiovascular abnormalities in Noonan syndrome: the clinical findings and treatments.

Acta paediatrica Japonica : Overseas edition, 1996

Research

Cardiac findings in 31 patients with Noonan's syndrome.

Arquivos brasileiros de cardiologia, 2000

Research

Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.

American journal of medical genetics. Part C, Seminars in medical genetics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.